Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inframat is a private U.S. nanotechnology and advanced materials company focused on developing and manufacturing nanostructured materials, thermal spray feedstocks, and functional coatings. Its business appears to center on industrial and infrastructure applications including wear resistance, corrosion protection, anti-biofouling, high-lubricity coatings, magnetic nanocomposites, and water-treatment materials. Publicly available descriptions also mention work related to medical implantable-device coatings, but the company does not appear to be a therapeutics or life sciences operating company. Inframat also sells advanced materials and provides sponsored research and joint development services to government, commercial, and research customers. Overall, it is best characterized as a commercial advanced-materials and coating company with some adjacent medtech-material relevance rather than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inframat.